Many women who have suffered from pelvic organ prolapse or stress urinary incontinence have been treated with transvaginal mesh implants. All too often, these mesh implants have caused painful complications because of mesh eroding, degrading, curling, rolling, migrating or shrinking.
The United States Food and Drug Administration (FDA) issued an alert in October 2008 about transvaginal mesh, warning doctors about the more than 1000 adverse event reports it had received in the previous three years. The reports included complaints of vaginal, bladder or bowel erosion, pelvic pain, bone and hip infections, inflammation, dyspareunia (painful sexual intercourse), bowel and bladder perforation, and recurrence of the underlying problem.
In July of 2100 the FDA issued a Safety Communication advising of 2,874 additional reports of complications. from 2008 to 2010.